With feminine good looks and freeride spirit, Resist from Julbo is up to any challenge and refuses to compromise. Effortlessly switching from town to mountains, it offers an outstanding level of performance: pantos shape and keyhole bridge for style, grip material, a curved front and temples to take on the worst situations, as well as photochromic Reactiv lenses for the best vision. 100% protection of your look.
Distributed by Lanctôt: www.rlanctot.com
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017. This disease affects approximately 200 Canadians. The treatment, developed by the Pennsylvania-based company Spark Therapeutics Inc., is known as Luxturna (voretigene neparvovecrzyl) and could be used to treat 6000 people worldwide.
“Today’s approval marks another first in the field of gene therapy—both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer to the treatment of vision loss—and this milestone reinforces the potential of this breakthrough approach in treating a widerange of challenging diseases. The culmination of decades of research has resulted in three gene therapy approvals this year for patients with serious and rare diseases. I believe gene therapy will become a mainstay in treating, and maybe curing, many of our most devastating and intractable illnesses,” said FDA Commissioner Scott Gottlieb, M.D.
Luxturna functions by delivering a working copy of the RPE65 gene to the retina, which then can produce the normal protein,
allowing the retina to function properly. The treatment is currently extremely expensive, costing $425,000 USD per eye.
The treatment is not yet approved by Health Canada.
Canadian Eye Care Business Review (CECBR), announces 2018 sponsors for the Canadian resource for independent eye care professionals. Each sponsor is committed to fostering the sustainability and health of independent eye care practices by financially supporting the initiative and through their content contributions to the site.
2018 Sponsors include:
CECBR was launched in 2017 in response to the need for a uniquely Canadian context for eye care business information. “The 2018 sponsors are confirming their commitment to the importance of independent eye care as a vital segment of the eye care services and eyewear market. They have expertise to share with ECPs, and are fully aligned with the site’s mission: to learn, engage and succeed,” said David Pietrobon, President of VuePoint IDS, CECBR’s publisher.
The site can be viewed at www.eyecarebusiness.ca
About Canadian Eye Care Business Review (CECBR)
CECBR is the only online digital resource focused on all aspects of independent eye care business practice in the Canadian market; from professional development and evolution for a new practice start-up, to the everyday challenges of operating a successful practice, through to exit strategies and retirement.
Drs. Tina and Jeff Goodhew, independent optometric practitioners from Oakville, Ontario, are Co-Editors in Chief.
Content is a combination of subject matter expertise and peer-to-peer sharing of experience and practical tips. Topical interactive webinars, articles and resources are available online at www.eyecarebusiness.ca and are also distributed through the weekly OptikXTRA electronic newsletter to over 3,000 Canadian Eye Care Practitioners.
For sponsorship information, please contact sales@vuepoint.ca
Westgroupe has announced the launch of the ZEISS 2018 Eyewear Collection in Canada.
Designed with the precision, high quality materials and proprietary technology, the eyewear collection launches with 14 styles; 7 men’s, 4 women’s & 3 unisex styles ranging from full rim to rimless and varied shapes. Constructed from high-quality materials, Titanium and TX5, the collection features Titanium nose pads in keeping with the luxury appeal of the brand. For those who prefer a softer touch, standard soft nose pads are also included with every frame. All styles feature the signature titanium temple tips.
Standouts from the women’s collection are models ZS-10007 (photo) and ZS-10011. Both styles feature TX5 fronts and titanium temples for a lightweight, easy-to-wear frame that retains its shape even in extreme heat.
For the men, this collection showcases classic eye shapes. ZS-20001 (photo) is a rectangular, matte finish TX5 frame that boasts a titanium inlay on the temples and end pieces.
Visit www.westgroupe.com for more information about the collection.
SAFILO announces an exclusive distribution partnership for Paraguay with CEPAL, a leading local Eyewear Company with a longstanding successful track record of quality eyewear distribution and service since 1981.
With this partnership, SAFILO further expands its footprint in Latin America in support of its growth plans in the region as part of its accelerated Emerging Markets expansion.
SAFILO’s renowned high-quality products representing a brand portfolio of over 30 leading eyewear brands are now offered in Paraguay in quality opticians, who are served by CEPAL on behalf of SAFILO with the highest levels of service.
Read full press release HERE.
HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.
Learn More
A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.
Read more
Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.
Read more
ZEISS introduces MyoActive in Canada, the first myopia management lens applying Dynamic Signal Theory through patented M.O.V.E. technology, supported by strong clinical evidence.
Read more
The 2026 SILMO d’Or winners highlight the industry’s creativity, innovation and exceptional craftsmanship through a diverse and forward looking awards line up.
Read more
HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.
Learn More A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.
Read More Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.
Read More ZEISS introduces MyoActive in Canada, the first myopia management lens applying Dynamic Signal Theory through patented M.O.V.E. technology, supported by strong clinical evidence.
Read More The 2026 SILMO d’Or winners highlight the industry’s creativity, innovation and exceptional craftsmanship through a diverse and forward looking awards line up.
Read More
HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.
Learn More A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.
Read more Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.
Read more ZEISS introduces MyoActive in Canada, the first myopia management lens applying Dynamic Signal Theory through patented M.O.V.E. technology, supported by strong clinical evidence.
Read more The 2026 SILMO d’Or winners highlight the industry’s creativity, innovation and exceptional craftsmanship through a diverse and forward looking awards line up.
Read more HOYA Vision Care launches LensPreview in Canada, a virtual try on tool that lets patients preview photochromic, polarized and mirror lenses in true to colour detail, enhancing confidence and supporting practice growth.
Learn More A new Canadian survey highlights opticians’ interest, involvement and training needs in supporting contact lens patients.
Read more Italian eyewear exports declined in early 2026 due to U.S. market weakness, but Europe’s resilience and improving monthly trends signal gradual recovery.
Read more ZEISS introduces MyoActive in Canada, the first myopia management lens applying Dynamic Signal Theory through patented M.O.V.E. technology, supported by strong clinical evidence.
Read more The 2026 SILMO d’Or winners highlight the industry’s creativity, innovation and exceptional craftsmanship through a diverse and forward looking awards line up.
Read more
